Annual CAPEX
$12.94 M
-$4.89 M-27.44%
December 31, 2023
Summary
- As of February 12, 2025, DNLI annual capital expenditures is $12.94 million, with the most recent change of -$4.89 million (-27.44%) on December 31, 2023.
- During the last 3 years, DNLI annual CAPEX has risen by +$9.84 million (+318.06%).
- DNLI annual CAPEX is now -27.79% below its all-time high of $17.92 million, reached on December 31, 2019.
Performance
DNLI CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2024
Summary
- DNLI quarterly capital expenditures is not available.
Performance
DNLI Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2024
Summary
- DNLI TTM capital expenditures is not available.
Performance
DNLI TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
DNLI CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.4% | - | - |
| 3 y3 years | +318.1% | - | - |
| 5 y5 years | +281.3% | - | - |
DNLI CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.4% | +52.2% | ||||
| 5 y | 5-year | -27.8% | +318.1% | ||||
| alltime | all time | -27.8% | +318.1% |
Denali Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $12.94 M(-27.4%) | - | - |
| Sep 2023 | - | $2.07 M(-64.6%) | $15.55 M(-20.4%) |
| Jun 2023 | - | $5.85 M(+110.0%) | $19.54 M(+17.8%) |
| Mar 2023 | - | $2.79 M(-42.5%) | $16.58 M(-7.0%) |
| Dec 2022 | $17.83 M(+109.8%) | $4.85 M(-19.9%) | $17.83 M(+11.2%) |
| Sep 2022 | - | $6.05 M(+109.1%) | $16.04 M(+35.2%) |
| Jun 2022 | - | $2.89 M(-28.4%) | $11.86 M(+21.8%) |
| Mar 2022 | - | $4.04 M(+32.4%) | $9.74 M(+14.6%) |
| Dec 2021 | $8.50 M(+174.6%) | $3.05 M(+62.8%) | $8.50 M(+28.0%) |
| Sep 2021 | - | $1.88 M(+142.9%) | $6.64 M(+21.4%) |
| Jun 2021 | - | $772.00 K(-72.4%) | $5.47 M(+9.1%) |
| Mar 2021 | - | $2.80 M(+134.3%) | $5.02 M(+62.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $3.10 M(-82.7%) | $1.20 M(+69.3%) | $3.10 M(-33.8%) |
| Sep 2020 | - | $706.00 K(+124.1%) | $4.67 M(-31.4%) |
| Jun 2020 | - | $315.00 K(-64.2%) | $6.81 M(-59.4%) |
| Mar 2020 | - | $879.00 K(-68.3%) | $16.77 M(-6.4%) |
| Dec 2019 | $17.92 M(+428.1%) | $2.77 M(-2.6%) | $17.92 M(+8.1%) |
| Sep 2019 | - | $2.85 M(-72.3%) | $16.58 M(+13.7%) |
| Jun 2019 | - | $10.27 M(+406.5%) | $14.58 M(+198.6%) |
| Mar 2019 | - | $2.03 M(+41.1%) | $4.88 M(+43.9%) |
| Dec 2018 | $3.39 M | $1.44 M(+69.7%) | $3.39 M(+73.5%) |
| Sep 2018 | - | $847.00 K(+48.1%) | $1.96 M(+76.4%) |
| Jun 2018 | - | $572.00 K(+6.5%) | $1.11 M(+106.5%) |
| Mar 2018 | - | $537.00 K | $537.00 K |
FAQ
- What is Denali Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Denali Therapeutics?
- What is Denali Therapeutics annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Denali Therapeutics?
- What is the all time high TTM CAPEX for Denali Therapeutics?
What is Denali Therapeutics annual capital expenditures?
The current annual CAPEX of DNLI is $12.94 M
What is the all time high annual CAPEX for Denali Therapeutics?
Denali Therapeutics all-time high annual capital expenditures is $17.92 M
What is Denali Therapeutics annual CAPEX year-on-year change?
Over the past year, DNLI annual capital expenditures has changed by -$4.89 M (-27.44%)
What is the all time high quarterly CAPEX for Denali Therapeutics?
Denali Therapeutics all-time high quarterly capital expenditures is $10.27 M
What is the all time high TTM CAPEX for Denali Therapeutics?
Denali Therapeutics all-time high TTM capital expenditures is $19.54 M